AMRX logo

Amneal Pharmaceuticals (AMRX) Cash From Investing

Annual CFI

-$63.00 M
+$6.19 M+8.95%

December 31, 2024

Summary

Performance

1-Year Change

+8.95%

3-Year Change

+67.56%

5-Year Change

-221.74%

15-Year Change

+36.08%

AMRX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

20.63%
AMRX annual cash flow from investing activities is higher than 20.63% of companies in Healthcare sector

High & Low

All-time High

-$19.58 M

3-Year Low

-$194.18 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
AMRX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
AMRX next annual earnings announcement has not yet been scheduled

OtherAMRXcash flowmetrics:

Annual CFF

-$211.79 M
AMRX annual cash flow from financing activities is -$211.79 million

Annual CFO

$295.10 M
AMRX annual cash flow from operations is $295.10 million

Annual FCF

$220.11 M
AMRX annual free cash flow is $220.11 million

Annual CAPEX

$74.99 M
AMRX annual capital expenditures is $74.99 million

Quarterly CFI

-$16.06 M
+$4.65 M+22.47%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+67.45%

5-Year Change

+49.49%

AMRX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

18.73%
AMRX quarterly cash flow from investing activities is higher than 18.73% of companies in Healthcare sector

High & Low

All-time High

$29.98 M
AMRX quarterly cash flow from investing activities is currently -153.56% below its historical high of $29.98 million

3-Year Low

-$97.39 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
AMRX previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
AMRX next earnings announcement is scheduled for May 2, 2025

OtherAMRXcash flowmetrics:

Quarterly CFF

-$61.20 M
AMRX quarterly cash flow from financing activities is -$61.20 million

Quarterly CFO

$118.08 M
AMRX quarterly cash flow from operations is $118.08 million

Quarterly FCF

$95.01 M
AMRX quarterly free cash flow is $95.01 million

Quarterly CAPEX

$23.06 M
AMRX quarterly capital expenditures is $23.06 million

TTM CFI

-$63.00 M
+$15.63 M+19.88%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+74.78%

5-Year Change

+80.16%

AMRX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

22.14%
AMRX TTM cash flow from investing activities is higher than 22.14% of companies in Healthcare sector

High & Low

All-time High

-$9.49 M

3-Year Low

-$278.88 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
AMRX previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
AMRX next earnings announcement is scheduled for May 2, 2025

OtherAMRXcash flowmetrics:

TTM CFF

-$211.79 M
AMRX TTM cash flow from financing activities is -$211.79 million

TTM CFO

$295.10 M
AMRX TTM cash flow from operations is $295.10 million

TTM FCF

$220.11 M
AMRX TTM free cash flow is $220.11 million

TTM CAPEX

$74.99 M
AMRX TTM capital expenditures is $74.99 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AMRX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.9%0.0%0.0%
3 y3 years+67.6%+67.5%+74.8%
5 y5 years-221.7%+49.5%+80.2%

AMRX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+67.6%-148.4%+83.5%-28.7%+77.4%
5 y5-year-221.7%+80.2%-236.9%+93.9%-221.7%+80.2%
alltimeall time-221.7%+84.1%-153.6%+95.3%-563.7%+84.3%

Amneal Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$63.00 M(-9.0%)
-$16.06 M(-22.5%)
-$63.00 M(-19.9%)
Sep 2024
-
-$20.71 M(+220.4%)
-$78.63 M(+10.1%)
Jun 2024
-
-$6.46 M(-67.3%)
-$71.39 M(-7.5%)
Mar 2024
-
-$19.76 M(-37.6%)
-$77.21 M(+11.6%)
Dec 2023
-$69.19 M(-60.3%)
-$31.69 M(+135.2%)
-$69.19 M(+41.3%)
Sep 2023
-
-$13.48 M(+9.7%)
-$48.96 M(-42.3%)
Jun 2023
-
-$12.28 M(+4.7%)
-$84.82 M(-4.3%)
Mar 2023
-
-$11.74 M(+2.4%)
-$88.65 M(-49.1%)
Dec 2022
-$174.31 M(-10.2%)
-$11.47 M(-76.8%)
-$174.31 M(-30.2%)
Sep 2022
-
-$49.33 M(+206.1%)
-$249.81 M(+17.8%)
Jun 2022
-
-$16.12 M(-83.5%)
-$212.11 M(-23.9%)
Mar 2022
-
-$97.39 M(+12.0%)
-$278.88 M(+43.6%)
Dec 2021
-$194.18 M
-$86.97 M(+647.6%)
-$194.18 M(+39.7%)
Sep 2021
-
-$11.63 M(-86.0%)
-$139.01 M(-2.2%)
Jun 2021
-
-$82.89 M(+553.0%)
-$142.16 M(+108.5%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$12.69 M(-60.1%)
-$68.20 M(-78.5%)
Dec 2020
-$317.55 M(+1521.8%)
-$31.80 M(+115.1%)
-$317.55 M(+9.3%)
Sep 2020
-
-$14.78 M(+65.6%)
-$290.52 M(+18.2%)
Jun 2020
-
-$8.93 M(-96.6%)
-$245.75 M(-5.5%)
Mar 2020
-
-$262.04 M(+5397.0%)
-$260.16 M(+1228.7%)
Dec 2019
-$19.58 M(-95.1%)
-$4.77 M(-115.9%)
-$19.58 M(+106.3%)
Sep 2019
-
$29.98 M(-228.5%)
-$9.49 M(-88.2%)
Jun 2019
-
-$23.33 M(+8.7%)
-$80.25 M(-79.9%)
Mar 2019
-
-$21.47 M(-503.4%)
-$398.35 M(+0.5%)
Dec 2018
-$396.38 M(+302.2%)
$5.32 M(-113.0%)
-$396.38 M(-1.3%)
Sep 2018
-
-$40.77 M(-88.1%)
-$401.70 M(+11.3%)
Jun 2018
-
-$341.43 M(+1651.0%)
-$360.92 M(+1751.0%)
Mar 2018
-
-$19.50 M
-$19.50 M
Dec 2017
-$98.55 M(-20.9%)
-
-
Dec 2016
-$124.61 M
-
-

FAQ

  • What is Amneal Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals annual CFI year-on-year change?
  • What is Amneal Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals quarterly CFI year-on-year change?
  • What is Amneal Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals TTM CFI year-on-year change?

What is Amneal Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of AMRX is -$63.00 M

What is the all time high annual CFI for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high annual cash flow from investing activities is -$19.58 M

What is Amneal Pharmaceuticals annual CFI year-on-year change?

Over the past year, AMRX annual cash flow from investing activities has changed by +$6.19 M (+8.95%)

What is Amneal Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of AMRX is -$16.06 M

What is the all time high quarterly CFI for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high quarterly cash flow from investing activities is $29.98 M

What is Amneal Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, AMRX quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Amneal Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of AMRX is -$63.00 M

What is the all time high TTM CFI for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high TTM cash flow from investing activities is -$9.49 M

What is Amneal Pharmaceuticals TTM CFI year-on-year change?

Over the past year, AMRX TTM cash flow from investing activities has changed by $0.00 (0.00%)